Back to search

Article

Optical genome mapping refines genomic risk stratification in therapy-related myeloid neoplasms and younger myelodysplastic syndromes

2026-08-25

Abstract excerpt

Accurate genomic characterization is essential for risk stratification in therapy-related myeloid neoplasms (t-MN) and younger myelodysplastic syndromes (yMDS), where chromosome banding analysis (CBA) has limited sensitivity. We analyzed 113 patients (48 t-MN, 65 yMDS) using optical genome mapping (OGM) integrated with CBA, targeted next-generation sequencing, and clinical data. OGM was interpretable in all cases...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
20a48640-d9e4-5c47-8f9d-3ed507f88fda
DOI
10.1038/s41698-026-01671-z
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optical genome mapping refines genomic risk stratification in therapy-related myeloid neoplasms and younger myelodysplastic syndromesDOI 10.1038/s41698-026-01671-z
Application of Optical Genome Mapping For Comprehensive Assessment of Chromosomal Structural Variants for Clinical Evaluation of Myelodysplastic SyndromesSemantic proximity
Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemiaSemantic proximity
Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patientsSemantic proximity
High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significanceSemantic proximity
Structural Variant Analysis of Complex Karyotype Myelodysplastic Neoplasia Through Optical Genome MappingSemantic proximity
Application of Optical Genome Mapping for the Diagnosis and Risk Stratification of Myeloid and Lymphoid MalignanciesSemantic proximity
Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML / MDS patientsSemantic proximity
Chromoanagenesis in Myelodysplastic Syndromes Is Associated With Highly Complex Karyotype, TP53 Disruption, and Dismal Prognosis.Semantic proximity
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNASemantic proximity
Optical Genome Mapping for Cytogenetic Diagnostics in AMLSemantic proximity
Genomic structural variants analysis in leukemia by a novel cytogenetic technique: Optical genome mappingSemantic proximity
Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome MappingSemantic proximity
Select a neighboring publication to make it the new centre.